Varenicline in smokers with diabetes: A pooled analysis of 15 randomized, placebo-controlled studies of varenicline
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Varenicline in smokers with diabetes: A pooled analysis of 15 randomized, placebo-controlled studies of varenicline
Authors
Keywords
-
Journal
Journal of Diabetes Investigation
Volume 8, Issue 1, Pages 93-100
Publisher
Wiley
Online
2016-05-26
DOI
10.1111/jdi.12543
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study
- (2015) Deborah Lycett et al. Lancet Diabetes & Endocrinology
- Retreatment With Varenicline for Smoking Cessation in Smokers Who Have Previously Taken Varenicline: A Randomized, Placebo-Controlled Trial
- (2014) D Gonzales et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Smoking cessation in adults with diabetes: a systematic review and meta-analysis of data from randomised controlled trials
- (2014) Alexander Nagrebetsky et al. BMJ Open
- Smoking Behavior among US Adults with Diabetes or Impaired Fasting Glucose
- (2013) Carole Clair et al. AMERICAN JOURNAL OF MEDICINE
- Effects of Varenicline on Smoking Cessation in Adults With Stably Treated Current or Past Major Depression
- (2013) Robert M. Anthenelli et al. ANNALS OF INTERNAL MEDICINE
- Association of Smoking Cessation and Weight Change With Cardiovascular Disease Among Adults With and Without Diabetes
- (2013) Carole Clair et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Use and Effectiveness of Quitlines for Smokers With Diabetes: Cessation and Weight Outcomes, Washington State Tobacco Quit Line, 2008
- (2013) Gillian L. Schauer et al. Preventing Chronic Disease
- A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Varenicline for Smoking Cessation in Patients With Schizophrenia or Schizoaffective Disorder
- (2012) Jill M. Williams et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Double-Blind Randomized Placebo-Controlled Pilot Study of Neuropsychiatric Adverse Events in Abstinent Smokers Treated with Varenicline or Placebo
- (2011) Dahlia Garza et al. BIOLOGICAL PSYCHIATRY
- Effects of Varenicline in Adult Smokers: A Multinational, 24-Week, Randomized, Double-Blind, Placebo-Controlled Study
- (2011) Chris T. Bolliger et al. CLINICAL THERAPEUTICS
- A Randomized Placebo-Controlled Trial of Varenicline for Smoking Cessation Allowing Flexible Quit Dates
- (2011) S. Rennard et al. NICOTINE & TOBACCO RESEARCH
- Effects of Varenicline on Smoking Cessation in Patients With Mild to Moderate COPD
- (2010) Donald P. Tashkin et al. CHEST
- Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease
- (2010) Nancy A. Rigotti et al. CIRCULATION
- All-Cause Mortality Risk Among a National Sample of Individuals With Diabetes
- (2010) K. M. Nelson et al. DIABETES CARE
- Varenicline for smoking cessation: A placebo-controlled, randomized study
- (2009) Chen WANG et al. RESPIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started